Aytu Biopharma (AYTU) Receivables - Net: 2015-2025
Historic Receivables - Net for Aytu Biopharma (AYTU) over the last 11 years, with Sep 2025 value amounting to $33.2 million.
- Aytu Biopharma's Receivables - Net rose 43.46% to $33.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.2 million, marking a year-over-year increase of 43.46%. This contributed to the annual value of $31.2 million for FY2025, which is 22.91% up from last year.
- As of Q3 2025, Aytu Biopharma's Receivables - Net stood at $33.2 million, which was up 6.64% from $31.2 million recorded in Q2 2025.
- In the past 5 years, Aytu Biopharma's Receivables - Net ranged from a high of $35.8 million in Q1 2025 and a low of $21.6 million during Q3 2021.
- Its 3-year average for Receivables - Net is $29.9 million, with a median of $29.9 million in 2024.
- As far as peak fluctuations go, Aytu Biopharma's Receivables - Net soared by 438.35% in 2021, and later fell by 22.55% in 2024.
- Over the past 5 years, Aytu Biopharma's Receivables - Net (Quarterly) stood at $23.0 million in 2021, then grew by 11.13% to $25.5 million in 2022, then grew by 15.09% to $29.4 million in 2023, then fell by 13.60% to $25.4 million in 2024, then soared by 43.46% to $33.2 million in 2025.
- Its Receivables - Net was $33.2 million in Q3 2025, compared to $31.2 million in Q2 2025 and $35.8 million in Q1 2025.